UKAD v Tyrell Wilson (SRU)
A decision in the case of UK Anti-Doping (UKAD) v Tyrell Wilson (SRU) has been published by the National Anti-Doping Panel (NADP).
On 13 January 2018 Mr Wilson, an Amateur rugby union player from Scotland, was subject to an In-Competition test following a match in which he played for Newton Stewart RFC.
Analysis of Mr Wilson’s urine sample returned an Adverse Analytical Finding methylenedioxymethamphetamine (‘MDMA’). MDMA is classified as a Specified Stimulant under section 6(b) of the WADA 2018 Prohibited List and is prohibited In-Competition only.
Mr Wilson was subsequently charged with committing an Anti-Doping Rule Violation (ADRV) pursuant to UK Anti-Doping Rule Article 2.1 in February 2018.
UKAD submitted that Mr Wilson should not have the benefit of the rebuttable presumption provided for in World Rugby Regulation 126.96.36.199, that the Prohibited Substance was taken Out-of-Competition. As a result, UKAD argued that the starting sanction should be four years, subject to any reduction applied by the Tribunal.
Having regard to the evidence before it, the Tribunal acknowledged that Mr Wilson had committed an ADRV, however was not convinced that he did so to cheat. The Tribunal found that UKAD did not establish to the Tribunal’s comfortable satisfaction that the ADRV was intentional.
As a result, the Tribunal imposed a period of Ineligibility of 2 years on Mr Wilson, to run from the date of Sample collection, January 13 2018.
The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping, who are responsible for investigating, charging and prosecuting cases before the NADP.